Table 1.
Metabolites Differing between Activated Transfected Killer (ATAK)– and Placebo-Treated Mice
| Superpathway | Pathway | Biochemical | Ratioa | P |
|---|---|---|---|---|
| Amino acid | Phenylalanine and tyrosine metabolism | Phenol sulfate | 1.45 | .04 |
| Valine, leucine, and isoleucine metabolism | 3-methyl-2-oxovalerate | 0.72 | .03 | |
| Lipid | Bile acid metabolism | β-muricholate | 0.50 | .05 |
| Deoxycholate | 0.70 | .01 | ||
| Peptide | Fibrinogen cleavage peptide | TDTEDKGEFLSEGGGV | 0.70 | .01 |
| Unidentified | Unidentified | Y-11835 | 2.07 | .003 |
| Y-11538 | 0.52 | .02 | ||
| Y-12138 | 0.52 | .02 | ||
| Y-11327 | 0.44 | .02 | ||
| Y-14603 | 2.65 | .03 | ||
| Y-14938 | 1.26 | .04 | ||
| Y-14588 | 0.80 | .05 | ||
| Y-12645 | 1.71 | .05 |
a Ratio of metabolite present in ATAK samples/placebo samples. Numbers >1 denote excess metabolite in ATAK samples, and numbers <1 denote diminished metabolite in ATAK samples.